Press

News Reports  |   Press Releases  |   Videos  |   Archived Press

 

News Reports

CELL: T-Scan: A Genome-wide Method for the Systematic Discovery of T Cell Epitopes
CELL: Volume 178, ISSUE 4, P1016-1028.e13, August 08, 2019
Read More

Novartis backs Harvard spinout's quest to build TCR repository in $48M round
Endpoints News: July 24, 2019
Read More

TScan Lands $48M for Better, Safer T-Cell Receptor Cancer Therapies
Xconomy: July 24, 2019
Read More

TScan Therapeutics uncloaks with $48M to unleash new TCR targets
FierceBiotech: July 24, 2019
Read More

Bayer, Longwood Back Star Researcher's Deep Dive into the Tumor Microenvironment for New I/O Targets
Endpoints News: July 17, 2019
Read More

New Drug Trial in Auckland Could Make Life Easier for Autistic Children
New Zealand Herald: May 17, 2019
Read More

Newly Discovered Link Between the Appendix and Parkinson’s Disease Could Point to the Way to Treatments
FierceBiotech, October 31, 2018
Read More

Renovia Closes on $42 Million Series B with CEO Marc Beer
Chronicle of the Week: October 19, 2018
Read More

A promising new minimally invasive procedure for skin contouring
Dermatology Times: October 17, 2018
Read More

GlaxoSmithKline Helps Immunometabolism Startup Sitryx to $30M Round
Fierce Biotech: October 8, 2018
Read More

Verastem Wins FDA Approval for Blood Cancer Drug
Boston Globe: September 25, 2018
Read More

Biotech Firm Grail Takes the First Steps in its Quest for a Blood Test for Cancer
Forbes: June 2, 2018
Read More

Axial Co-Founder Sarkis Mazmanian: What's Living in You?
Discover how a world of microbes living in and on you can make you sick-and keep you healthy. PBS, NOVA: May 2, 2018
Watch Nova

One Scientist’s Marathon Quest for the Exercise Pill
Bloomberg Businessweek: October 17, 2017
Read More

Silicon Valley Startup Grail Sees Hope for Cancer Blood Test
Bloomberg News: August 9, 2017
Read More

Rich Aldrich Honored as One of the 100 Most Influential Visionaries in Biotech
Scientific American Worldview: The Visionaries who Continue to Reshape Biotechnology – and the World
Read More

 

Press Releases

Pulmocide announces Journal of Antimicrobial Chemotherapy publication of novel antifungal PC945 activity against Candida auris, a health threat gaining global prominence
Read More

TScan Therapeutics Announces Pioneering Publication in Scientific Journal Cell Describing New Methods to Identify Targets for T Cell Receptor Immunotherapy
Read More

Millendo Therapeutics Reports Second Quarter 2019 Operating and Financial Results
Read More

Bicycle Therapeutics Reports Second Quarter 2019 Financial Results and Provides Clinical Update
Read More

Verastem Oncology Reports Second Quarter 2019 Financial Results and Highlights Recent Company Progress
Read More

Verastem Oncology Signs an Exclusive License Agreement with Sanofi
Read More

TScan Therapeutics Formed to Overcome Challenges of Current Immunotherapies with Novel TCR Discovery Platform and $48 Million in Funding
Read More

In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris
Read More

Pyxis Oncology Founded by Longwood Fund with Financing Led by Bayer
Read More

Axial Biotherapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of AB-2004 for Treatment of Gastrointestinal Dysfunction and Associated Behavioral Symptoms of Autism Spectrum Disorder
Read More

KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results
Read More

Calithera Biosciences Initiates Phase 1/2 Trial of Telaglenastat in Combination with Pfizer’s CDK4/6 Inhibitor Palbociclib
Read More

Pulmocide Announces Nature Research Publication Showing PC945 in Combination with Standard Antifungal Treatment Causes a Synergistic Effect Against Aspergillus Fumigatus
Read More

Bicycle Therapeutics Announces Positive Topline Results from Oxurion’s Phase I Trial Using a Novel Bicycle-based Plasma Kallikrein Inhibitor for the Treatment of Diabetic Macular Edema
Read More

PTC Therapeutics Announces Strategic Gene Therapy Licensing Agreement with Odylia Therapeutics
Read More

Axial Biotherapeutics Announces $10M Investment from Taiho Ventures to Access Axial’s Expertise in the Gut-Brain Axis
Read More

Calithera Achieves Positive Topline Results in Randomized Phase 2 Study in Renal Cell Carcinoma
Read More

Colorescience Announces US Patent for Total Eye 3-in-1 Renewal Therapy SPF 35
Read More

PTC Receives FDA Approval for the Expansion of the EMFLAZA Labeling to Include Patients 2-5 Years of Age
Read More

GRAIL Announces Appointment of Hans Bishop as Chief Executive Officer
Read More

GRAIL Announces Positive New Data with Multi-Cancer Early Detection Blood Test from CCGA Study
Read More

Axial Announces Publication of Preclinical Data Highlighting the Link Between Human Gut Microbiota and Behavioral Symptoms of Autism Spectrum Disorder in Mouse Models
Read More

Bicycle Therapeutics Announces Pricing of Initial Public Offering
Read More

KalVista Pharmaceuticals to Present Data at Upcoming Scientific Conferences
Read More

Recros Medica Announces Positive 90-Day Results from CONFORM Study
Read More

Pulmocide Presents Clinical Update from Promising Antifungal Program at 2019 Respiratory Innovation Summit
Read More

ArcherDX Announces Close of $60M Financing to Advance Companion Diagnostic and Minimal Residual Disease Monitoring Product Portfolio
Read More

GRAIL Announces Promising New Data with Early Detection Blood Test to be Presented at ASCO
Read More

Verastem to Present New COPIKTRA Dose Modification Data from Patients Treated in the Phase 3 DUO Study
Read More

GRAIL Announces Significant Progress with Multi-Cancer Early Detection Test Including FDA Breakthrough Device Designation
Read More

Verastem Reports First Quarter 2019 Financial Results, $1.7M in Net Product Revenues
Read More

Bicycle Therapeutics Enters Neuroscience Arena through Collaboration with Dementia Discovery Fund
Read More

FDA Accepts Recros Medica De Novo Submission for Nuvellus Focal Contouring System
Read More

GRAIL Licenses Nasopharyngeal Cancer Early Detection Technology to TAKE2
Read More

Axial Biotherapeutics Releases New Preclinical Data from AB-2004 Program Demonstrating Reduction of Microbiome-Derived Metabolites in Mouse Models with Autism Spectrum Disorder
Read More

Colorescience Reveals Clinical Advancements to Reduce Redness Associated with Rosacea
Read More

Bicycle Therapeutics and Oxurion Announce Full Enrollment in Phase I Trial for the Treatment of Diabetic Macular Edema
Read More

Channel Medsystems Receives U.S. FDA Approval of the Cerene Cryotherapy Device
Read More

Millendo Reports Full Year 2018 Operating and Financial Results
Read More

ArcherDX announces collaboration with University College London to Investigate the Novel Use of Cell-Free Tumor DNA to Detect Disease Recurrence in Lung Cancer Patients
Read More

Calithera Biosciences Initiates Phase 1/2 Trial of Telaglenastat in Combination with the PARP Inhibitor Talazoparib
Read More

Millendo Initiates Pivotal Phase 2b/3 Clinical Study of Livoletide for the Treatment of Prader-Willi Syndrome
Read More

KalVista Pharmaceuticals Reports Fiscal Third Quarter Results

ArcherDX Announces Expansion of Executive Leadership Team as Company Continues to Experience Rapid Growth
Read More

PTC to Expand Product Portfolio in Latin America with WAYLIVRA™
Read More

Axial Biotherapeutics Raises $25 Million in Series B Financing
Read More

KalVista Pharmaceuticals Presents Data at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
Read More

Calithera Biosciences Initiates Phase 1 Trial of Arginase Inhibitor CB-280 for the Treatment of Cystic Fibrosis
Read More

Verastem Oncology Announces Key Management Appointments
Read More

Bicycle Therapeutics Strengthens Executive Team with Key Changes
Read More

Bicycle Therapeutics Announces Publication of Its Paper Demonstrating Utility of Bicycles™ as Imaging Agents
Read More

Verastem Announces Publication of Phase 2 Study Results in Indolent Non-Hodgkin Lymphoma in the Journal of Clinical Oncology
Read More

Bicycle Therapeutics Awarded SBRI Contract to Address Antimicrobial Resistance in Humans
Read More

ArcherDX Announces Broad-Based Strategic Collaboration with Genosity
Read More

Calithera Completes Patient Enrollment in Randomized Phase 2 Trial in Renal Cell Carcinoma
Read More

KalVista Appoints Brian J. G. Pereira, MD to Board of Directors
Read More

PTC Therapeutics Launches New Program to Support Research Projects in Rare, Genetic Disorders
Read More

ArcherDX Acquires Baby Genes, a Genetics-Based Personalized Medicine Company
Read More

Renovia Appoints John A. Fallon, M.D. to Its Board of Directors
Read More

ArcherDX's Companion Diagnostic Assay for both Liquid Biopsy and Tissue Specimens Granted Breakthrough Device Designation by FDA
Read More

Calithera Biosciences Provides Corporate Updates and Announces Key Executive Promotions to Drive Continued Growth of the Company’s Pipeline
Read More

KalVista Pharmaceuticals Provides Development Update and 2019 Clinical Plans
Read More

Verastem Oncology Outlines Strategic Priorities for 2019 and Highlights Recent Progress
Read More

Recros Medica's Rotational Fractional Resection Hits the Sweet Spot for a More Defined Neckline
Read More

GRAIL Announces Plans to Initiate SUMMIT Study to Support Development of Blood Test for Early Cancer Detection
Read More

KalVista Pharmaceuticals Provides Clinical Update on KVD900
Read More

Renovia Launches a Multi-Center RCT to Study Next-Generation leva® Pelvic Digital Therapeutic System for UI
Read More

Sygnature Discovery & Sitryx Therapeutics Enter Drug Discovery Deal
Read More

Verastem Oncology Reports Third Quarter 2018 Financial Results
Read More

Verastem Oncology Announces Presentation of Preclinical Data Supporting Dual PI3K-delta and PI3K-gamma Inhibition in Combination with Immunotherapy
Read More

Axial Biotherapeutics Strengthens Senior Management Team with Appointment of Jeff Young as Chief Financial Officer
Read More

GRAIL to Present New Data from the Circulating Cell-free Genome Atlas (CCGA) Study at ESMO
Read More

Recros Medica Showcases Interim Data on Rotational Fractional Resection Technology
Read More

New Biopharmaceutical Company Sitryx Launches with $30 Million Fundraising to Develop Disease Modifying Therapeutics in Immunometabolism
Read More

Merck KGaA, Darmstadt, Germany Selects ArcherDX for Strategic Global Companion Diagnostic Assay Development Collaboration
Read More

GRAIL Announces Appointment of Renée Galá as Chief Financial Officer
Read More

Bicycle Therapeutics’ Founder Sir Gregory Winter Awarded Nobel Prize in Chemistry
Read More

Recros Medica Unveils the Nuvellus™ Brand for Its Novel Rotational Fractional Resection Technology
Read More

Verastem Oncology Signs Exclusive License Agreement for the Development and Commercialization of COPIKTRA™ (duvelisib) in China
Read More

Millendo Therapeutics Appoints Acceleron CEO Habib Dable to its Board of Directors
Read More

Longwood-Founded Verastem Oncology Receives FDA Approval of COPIKTRA™ (duvelisib) Capsules
Read More

KalVista Pharmaceuticals Reports Fiscal First Quarter Results
Read More

IlluminOss Medical Receives Clearance to Expand Clinical Indications in the US
Read More

Millendo Announces Initiation of Phase 2b Clinical Trial of Nevanimibe in Patients with Classic CAH
Read More

IlluminOss Medical Receives Clearance to Expand Clinical Indications in the US
Read More

KalVista Pharmaceuticals Announces the Closing of its Public Offering of Common Stock and Full Exercise of the Underwriters’ Over-allotment Option to Purchase Additional Shares
Read More

ArcherDX Names Former Foundation Medicine Executive Steven Kafka, Ph.D. to its Board of Directors
Read More

Twentyeight-Seven Therapeutics Launches with a $65 Million Series A Funding
Read More

Verastem Oncology Announces Investigator Sponsored Study on Duvelisib in Combination with Venetoclax
Read More

Colorescience Product Wins Second O-Ward
Read More

Amgen Co-Founder and NAS Member Marvin H. Caruthers, PhD, Joins Board of ArcherDX
Read More

Astellas Completes Acquisition of Mitobridge, Inc.
Read More

Recros Medica Closes $9M Financing, Strengthens Board
Read More

Millendo Acquires Alizé Pharma SAS to Expand Orphan Endocrinology Pipeline
Read More

Millendo Therapeutics Announces Positive Phase 2 Results in Classic Congenital Adrenal Hyperplasia, Receives FDA Orphan Drug Designation
Read More

Flex Pharma Announces Positive Phase 2 ALS Results
Read More

KalVista Pharmaceuticals Announces Collaboration with Merck
Read More

Verastem Announces Positive Top-line Data from the Pivotal Phase 3 DUO™ Study in Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Read More

Bioverativ and Bicycle Therapeutics Enter into Strategic Research Collaboration to Develop Therapies for Hemophilia and Sickle Cell Disease
Read More

Bicycle Therapeutics Closes £40 Million ($52 Million) in Series B Financing to Advance Clinical Pipeline
Read More

GRAIL Initiates the STRIVE Study to Advance Development of Blood Tests to Detect Cancer Early
Read More

 

Videos